The Motley Fool Previous Page

2-Star Stocks Poised to Plunge: Nymox Pharmaceutical?

Brian D. Pacampara
November 12, 2012

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company Nymox Pharmaceutical (Nasdaq: NYMX  ) has received a distressing two-star ranking.

With that in mind, let's take a closer look at Nymox and see what CAPS investors are saying about the stock right now.

Nymox facts

Headquarters (founded)

St Laurent, Canada (1989)

Market Cap

$279.1 million



Trailing-12-Month Revenue